We’ll explore how Array’s integration of APA’s fixed-tilt and A-frame designs opens new possibilities in difficult terrains and why foundation choice is critical to structural resilience and long-term ...

Array Digital Infrastructure's cell tower business grew by 68% over its year-ago comp following T-Mobile's master license agreement. The tower company is set to see some near-term headwinds as DISH ...

With global shipping responsible for 3% of greenhouse gases, one startup’s quicklime-powered tech promises to make cargo ships more climate-friendly, by turning exhaust fumes into harmless limestone ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Add Yahoo as a preferred source to see more of our stories on Google. A new report suggests increased investments in solar power on school grounds could help reduce energy costs in Centre County and ...

Array Technologies Inc. (NASDAQ:ARRY) is one of the best solar stocks to buy according to Wall Street analysts. On August 14, Array Technologies announced the successful completion of its acquisition ...

Albuquerque-based Array Technologies reported Thursday a 20% jump in revenue from the previous quarter, beating analyst expectations. In an earnings call, company officials reported $362.2 million in ...

When you’re stuck in a rut, moving forward can feel impossible. Here are five ways to try to progress through struggles Often solutions to our problems are within our reach, but fear of failure, ...

GUANGZHOU, China, July 2, 2025 /PRNewswire/ -- Bio-Thera Solutions, Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today ...

Opus Genetics, Inc. announced positive topline results from its VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating presbyopia, achieving its primary and key ...

VEGA-3 trial showed significant efficacy of phentolamine ophthalmic solution 0.75% in improving near vision in presbyopia patients compared to placebo. The trial met its primary endpoint with 27.2% ...